PAREXEL International

493 articles with PAREXEL International

• Parexel Expands Collaboration with SCRS Through Leadership of Patient-Focused Initiatives to Drive Engagement and Diversity in Clinical TrialsAs a Site Engagement Partner, Parexel will help to enrich connections between sit

  10/31/2019

  Parexel announced the expansion of its collaboration with the Society for Clinical Research Sites, the first and only global organization fully dedicated to representing the interests of clinical research sites.

• 

  BioSpace Movers & Shakers, Oct. 11

  10/11/2019

  Companies strengthen their leadership teams and boards of directors with these appointments.
• 

  Datavant and Parexel Partner to Harness Real-World Evidence

  10/10/2019

  Through the partnership, Parexel will integrate Datavant’s connectivity technology into the workflow of all of its clinical studies.

• Datavant Announces Strategic Partnerships and Corporate Milestones

  10/9/2019

  Datavant, the leader in helping healthcare organizations connect and share health data, announced a series of corporate updates.

• CMAB Biopharma Receives Positive Opinion Following External Quality Audit

  9/5/2019

  CMAB Biopharma (Suzhou) Inc. announced a positive opinion in an external European quality audit conducted by Parexel International Co.

• Parexel Appoints Gavin Nichols to Lead Informatics and Information Technology

  8/5/2019

  Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through to Commercialization, today announced Gavin Nichols has joined the company as Executive Vice President, Informatics and Information Technology.

• Parexel’s Peyton Howell Named to 2019 PharmaVOICE 100

  8/1/2019

  EVP and Chief Commercial & Strategy Officer recognized as one of the 100 most inspiring people in life sciences for healthcare industry leadership and patient focus

• Parexel Extends Asia/Pacific Capability with the Launch of Health Advances Asia Limited

  7/23/2019

  Strategic Healthcare Consulting subsidiary will support development of global expansion strategies for Asia/Pacific and multinational companies from new Hong Kong presence; biopharma and medtech veteran Gary Cheng to lead local team

• Parexel Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships

  6/23/2019

  Parexel FSP provides biopharmaceutical customers the full spectrum of outsourcing solutions from full service to functional to a hybrid approach across a range of specialized disciplines including Clinical, Data Management, Safety, Regulatory and Medical Affairs

• Parexel Strengthens Risk-Based Monitoring Offering with New Advanced Statistical Capabilities

  6/18/2019

  Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs

• Parexel Teams with CLARINESS to Enhance Patient Access and Engagement in China

  6/12/2019

  Collaboration expands Parexel’s capabilities in the region for patient access through China’s native social media channels; enhances ongoing engagement through CLARINESS’s digital patient recruitment portal

• 

  Recent Facility and Job Expansions in the Biopharma Industry

  6/7/2019

  There has been a spate of recent news regarding the expansion of facilities and the expected job growth for the biopharma and life sciences industry. Here’s a look at some of those stories.

• Parexel Unveils Oncology Center of Excellence to Support Acceleration of Patient-Focused Oncology Drug Development

  5/29/2019

  Parexel International, a leader in supporting the biopharma industry in oncology drug development, unveiled its Oncology Center of Excellence.

• PAREXEL Ranked #1 Among Global CROs for Leadership in Phase II/III Clinical Research in Prominent Annual ISR CRO Quality Benchmark Survey

  4/2/2019

  Company recognized for service provider leadership among global customers

• 

  BioSpace Movers and Shakers: March 15

  3/15/2019

  Biotech and pharma companies make changes to their executive leadership teams, with moves at Sandoz, PAREXEL, FSD, Karuna, Precision Bio, and more.

• PAREXEL Expands Oncology Expertise Through FDA and Medical Oncologist Appointments

  2/27/2019

  Additions support increased demand and complexity in oncology drug development and commercialization

• 

  BioSpace Movers and Shakers: Feb. 15

  2/15/2019

  Pharma and biotech companies strengthen their leadership teams with new hires and appointments at Cadent, bluebird, Abeona, Sanofi, and more.

• PAREXEL Appoints Former FDA Senior Executives to Global Regulatory Consulting Services

  2/12/2019

  The new additions join more than 60 former global regulators in the group and will be focused on helping companies understand and work within the current FDA and global regulatory climates to optimize drug development and mitigate risk of unnecessary delays.

• PAREXEL Receives Consecutive Recognitions from Forbes and FlexJobs for its Workplace Culture

  1/28/2019

  Company has once again been recognized for its diverse and flexible workplace by Forbes and FlexJobs.

• PAREXEL Introduces New Dedicated Division to Help Emerging Biotech Companies Reach their Goals Quickly and Cost-Effectively

  1/6/2019

  PAREXEL International Corporation today introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively.